Stokes Capital Advisors, LLC Amgen Inc Transaction History

Stokes Capital Advisors, LLC

$338 Million
Q1 2024

A detailed history of Stokes Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Stokes Capital Advisors, LLC holds 1,845 shares of AMGN stock, worth $573,573. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,845

Previous 2,175 15.17%

Holding current value

$573,573

Previous $626,000 16.29%

% of portfolio

0.16%

Previous 0.2%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $88,727 - $107,104	-330 Reduced 15.17%	1,845 $524,000
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $20,456 - $23,076	-80 Reduced 3.55%	2,175 $626,000
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $18,585 - $23,074	-85 Reduced 3.63%	2,255 $606,000
Q1 2023 Apr 12, 2023	BUY	$225.79 - $275.2 $528,348 - $643,968	2,340 New	2,340 $565,000
Q4 2019 Jan 23, 2020	SELL	$189.21 - $243.2 $2.37 Million - $3.05 Million	-12,531 Closed	0 $0

Q3 2019 Oct 24, 2019	SELL	$174.11 - $208.62 $13,928 - $16,689	-80 Reduced 0.63%	12,531 $2.43 Million
Q2 2019 Jul 15, 2019	SELL	$166.7 - $195.41 $100,353 - $117,636	-602 Reduced 4.56%	12,611 $2.32 Million
Q1 2019 May 03, 2019	BUY	$180.87 - $203.88 $70,177 - $79,105	388 Added 3.03%	13,213 $2.51 Million
Q4 2018 Jan 15, 2019	BUY	$178.4 - $208.25 $192,672 - $224,910	1,080 Added 9.2%	12,825 $2.5 Million
Q3 2018 Oct 12, 2018	BUY	$185.29 - $208.89 $38,910 - $43,866	210 Added 1.82%	11,745 $2.44 Million
Q2 2018 Jul 13, 2018	BUY	$166.05 - $186.51 $117,065 - $131,489	705 Added 6.51%	11,535 $2.13 Million
Q1 2018 Apr 10, 2018	BUY	$169.43 - $198.0 $189,592 - $221,562	1,119 Added 11.52%	10,830 $1.85 Million
Q4 2017 Apr 05, 2018	BUY	$168.79 - $188.59 $1.64 Million - $1.83 Million	9,711	9,711 $1.69 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Capital Advisors, LLC with notifications on news.

Account

Stokes Capital Advisors, LLC Amgen Inc Transaction History